Pazopanib, sold under the brand name Votrient, is an anti-cancer medication marketed worldwide by Novartis. It is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis.

Nov 13, 2024 · What is pazopanib? Pazopanib is used to treat advanced renal cell carcinoma (kidney cancer). Pazopanib is also used to treat soft tissue sarcoma (a tumor that can develop in or around muscles, tendons, joints, organs, or blood vessels). Pazopanib is usually given after other treatments have failed.

Apr 1, 2025 · Pazopanib is a cancer medicine that is used to treat patients with kidney cancer (advanced renal cell carcinoma). It is also used to treat advanced soft tissue sarcoma (STS) in patients who have received other cancer treatments.

Pazopanib is used to treat certain types of cancer (kidney, soft tissue sarcoma). Pazopanib belongs to a class of drugs known as tyrosine kinase inhibitors.

Pazopanib hydrochloride is approved to treat adults with: Renal cell carcinoma (a type of kidney cancer) that is advanced. Soft tissue sarcoma that is advanced. It is used in patients who have already been treated with chemotherapy. Pazopanib hydrochloride is also being studied in the treatment of other types of cancer. More About Pazopanib ...

Pazopanib is used to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the cells of the kidneys) in adults. Pazopanib is in a class of medications called kinase inhibitors. It works by slowing or stopping the spread of cancer cells.

PAZOPANIB (paz OH pa nib) treats kidney cancer. It may also be used to treat sarcoma, a cancer that occurs in bone and connective tissues, such as fat, muscle, and blood vessels. It works by blocking a protein that causes cancer cells to grow and multiply.

Pazopanib blocks the proteins (kinases) from sending signals to cancer cells to grow. Blocking the signals causes the cancer cells to die. Pazopanib can also stop the cancer cells from developing new blood vessels.

Indicated for advanced renal cell carcinoma (RCC) 800 mg PO qDay on empty stomach (at least 1 hr ac or 2 hr pc) Continue until disease progression or unacceptable toxicity. Indicated for...

Jun 6, 2024 · Pazopanib (Votrient) is a type of targeted cancer drug for the treatment of kidney cancer. Find out how you have it, possible side effects and other important information.